As of 2026-01-03, the EV/EBITDA ratio of bluebird bio Inc (BLUE) is -1.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLUE's latest enterprise value is 129.30 mil USD. BLUE's TTM EBITDA according to its financial statements is -116.20 mil USD. Dividing these 2 quantities gives us the above BLUE EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 15.4x | 15.2x |
| Forward P/E multiples | 18.3x - 41.2x | 21.9x |
| Fair Price | (225.45) - (190.79) | (228.42) |
| Upside | -4636.3% - -3938.9% | -4696.0% |
| Date | EV/EBITDA |